sulfur hexafluoride lipid-type a microspheres
Generic: SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES·Brand: LUMASON
sulfur hexafluoride lipid-type a microspheres: 1 clinical trial tracked.
sulfur hexafluoride lipid-type a microspheres evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about sulfur hexafluoride lipid-type a microspheres, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
A Safety and Feasibility Study of NeuroNavigation-Guided Low Intensity Focused Ultrasound With Microbubbles to Enhance Nivolumab Delivery for the Treatment of Relapsed and Progressive Diffuse Midline Glioma and Other High Grade Brain Tumors
Primary endpoint: Incidence of dose limiting toxicities (DLT) as assessed by CTCAE v6.0.
Interventionalopen30 targetStarted 2026-09Completion 2030-121 site · United StatesChildren's National Research Institute